Circulating tumor cells participate in the formation of microvascular invasion and impact on clinical outcomes in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is a common malignant tumor worldwide. Although the treatment strategies have been improved in recent years, the long-term prognosis of HCC is far from satisfactory mainly due to high postoperative recurrence and metastasis rate. Vascular tumor thrombus, including micr...

Full description

Bibliographic Details
Main Authors: Bin Sun, Wei-Dan Ji, Wen-Chao Wang, Lei Chen, Jun-Yong Ma, Er-Jiang Tang, Mou-Bin Lin, Xiao-Feng Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2023.1265866/full
_version_ 1797640146530598912
author Bin Sun
Wei-Dan Ji
Wen-Chao Wang
Lei Chen
Jun-Yong Ma
Er-Jiang Tang
Mou-Bin Lin
Xiao-Feng Zhang
author_facet Bin Sun
Wei-Dan Ji
Wen-Chao Wang
Lei Chen
Jun-Yong Ma
Er-Jiang Tang
Mou-Bin Lin
Xiao-Feng Zhang
author_sort Bin Sun
collection DOAJ
description Hepatocellular carcinoma (HCC) is a common malignant tumor worldwide. Although the treatment strategies have been improved in recent years, the long-term prognosis of HCC is far from satisfactory mainly due to high postoperative recurrence and metastasis rate. Vascular tumor thrombus, including microvascular invasion (MVI) and portal vein tumor thrombus (PVTT), affects the outcome of hepatectomy and liver transplantation. If vascular invasion could be found preoperatively, especially the risk of MVI, more reasonable surgical selection will be chosen to reduce the risk of postoperative recurrence and metastasis. However, there is a lack of reliable prediction methods, and the formation mechanism of MVI/PVTT is still unclear. At present, there is no study to explore the possibility of tumor thrombus formation from a single circulating tumor cell (CTC) of HCC, nor any related study to describe the possible leading role and molecular mechanism of HCC CTCs as an important component of MVI/PVTT. In this study, we review the current understanding of MVI and possible mechanisms, discuss the function of CTCs in the formation of MVI and interaction with immune cells in the circulation. In conclusion, we discuss implications for potential therapeutic targets and the prospect of clinical treatment of HCC.
first_indexed 2024-03-11T13:27:43Z
format Article
id doaj.art-a971196182904e7298071966395caa2c
institution Directory Open Access Journal
issn 1664-8021
language English
last_indexed 2024-03-11T13:27:43Z
publishDate 2023-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj.art-a971196182904e7298071966395caa2c2023-11-03T05:51:50ZengFrontiers Media S.A.Frontiers in Genetics1664-80212023-11-011410.3389/fgene.2023.12658661265866Circulating tumor cells participate in the formation of microvascular invasion and impact on clinical outcomes in hepatocellular carcinomaBin Sun0Wei-Dan Ji1Wen-Chao Wang2Lei Chen3Jun-Yong Ma4Er-Jiang Tang5Mou-Bin Lin6Xiao-Feng Zhang7Center for Clinical Research and Translational Medicine, Yangpu Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Molecular Oncology, Eastern Hepatobiliary Surgical Hospital and National Center for Liver Cancer, Navy Military Medical University, Shanghai, ChinaDepartment of General Surgery, Yangpu Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of General Surgery, Yangpu Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Navy Military Medical University, Shanghai, ChinaCenter for Clinical Research and Translational Medicine, Yangpu Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of General Surgery, Yangpu Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Navy Military Medical University, Shanghai, ChinaHepatocellular carcinoma (HCC) is a common malignant tumor worldwide. Although the treatment strategies have been improved in recent years, the long-term prognosis of HCC is far from satisfactory mainly due to high postoperative recurrence and metastasis rate. Vascular tumor thrombus, including microvascular invasion (MVI) and portal vein tumor thrombus (PVTT), affects the outcome of hepatectomy and liver transplantation. If vascular invasion could be found preoperatively, especially the risk of MVI, more reasonable surgical selection will be chosen to reduce the risk of postoperative recurrence and metastasis. However, there is a lack of reliable prediction methods, and the formation mechanism of MVI/PVTT is still unclear. At present, there is no study to explore the possibility of tumor thrombus formation from a single circulating tumor cell (CTC) of HCC, nor any related study to describe the possible leading role and molecular mechanism of HCC CTCs as an important component of MVI/PVTT. In this study, we review the current understanding of MVI and possible mechanisms, discuss the function of CTCs in the formation of MVI and interaction with immune cells in the circulation. In conclusion, we discuss implications for potential therapeutic targets and the prospect of clinical treatment of HCC.https://www.frontiersin.org/articles/10.3389/fgene.2023.1265866/fullcirculating tumor cellsmicrovascular invasionrecurrence and metastasisclinical treatmenthepatocellular carcinoma
spellingShingle Bin Sun
Wei-Dan Ji
Wen-Chao Wang
Lei Chen
Jun-Yong Ma
Er-Jiang Tang
Mou-Bin Lin
Xiao-Feng Zhang
Circulating tumor cells participate in the formation of microvascular invasion and impact on clinical outcomes in hepatocellular carcinoma
Frontiers in Genetics
circulating tumor cells
microvascular invasion
recurrence and metastasis
clinical treatment
hepatocellular carcinoma
title Circulating tumor cells participate in the formation of microvascular invasion and impact on clinical outcomes in hepatocellular carcinoma
title_full Circulating tumor cells participate in the formation of microvascular invasion and impact on clinical outcomes in hepatocellular carcinoma
title_fullStr Circulating tumor cells participate in the formation of microvascular invasion and impact on clinical outcomes in hepatocellular carcinoma
title_full_unstemmed Circulating tumor cells participate in the formation of microvascular invasion and impact on clinical outcomes in hepatocellular carcinoma
title_short Circulating tumor cells participate in the formation of microvascular invasion and impact on clinical outcomes in hepatocellular carcinoma
title_sort circulating tumor cells participate in the formation of microvascular invasion and impact on clinical outcomes in hepatocellular carcinoma
topic circulating tumor cells
microvascular invasion
recurrence and metastasis
clinical treatment
hepatocellular carcinoma
url https://www.frontiersin.org/articles/10.3389/fgene.2023.1265866/full
work_keys_str_mv AT binsun circulatingtumorcellsparticipateintheformationofmicrovascularinvasionandimpactonclinicaloutcomesinhepatocellularcarcinoma
AT weidanji circulatingtumorcellsparticipateintheformationofmicrovascularinvasionandimpactonclinicaloutcomesinhepatocellularcarcinoma
AT wenchaowang circulatingtumorcellsparticipateintheformationofmicrovascularinvasionandimpactonclinicaloutcomesinhepatocellularcarcinoma
AT leichen circulatingtumorcellsparticipateintheformationofmicrovascularinvasionandimpactonclinicaloutcomesinhepatocellularcarcinoma
AT junyongma circulatingtumorcellsparticipateintheformationofmicrovascularinvasionandimpactonclinicaloutcomesinhepatocellularcarcinoma
AT erjiangtang circulatingtumorcellsparticipateintheformationofmicrovascularinvasionandimpactonclinicaloutcomesinhepatocellularcarcinoma
AT moubinlin circulatingtumorcellsparticipateintheformationofmicrovascularinvasionandimpactonclinicaloutcomesinhepatocellularcarcinoma
AT xiaofengzhang circulatingtumorcellsparticipateintheformationofmicrovascularinvasionandimpactonclinicaloutcomesinhepatocellularcarcinoma